[Ipilimumab-induced hypophysitis]

Rofo. 2013 Mar;185(3):268-9. doi: 10.1055/s-0032-1325515. Epub 2012 Nov 15.
[Article in German]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / pathology
  • Brain Neoplasms / secondary*
  • Diagnosis, Differential
  • Dose-Response Relationship, Drug
  • Female
  • Frontal Lobe / drug effects
  • Frontal Lobe / pathology
  • Humans
  • Image Interpretation, Computer-Assisted*
  • Infusions, Intravenous
  • Ipilimumab
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / secondary*
  • Magnetic Resonance Imaging*
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Melanoma / secondary*
  • Middle Aged
  • Neoplasm Staging
  • Pituitary Diseases / chemically induced*
  • Pituitary Diseases / diagnosis
  • Pituitary Gland / drug effects*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Ipilimumab